Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: A possible comeback for a failed sickle cell gene therapy

Three years ago, a trial for a sickle cell gene-editing therapy a decade in the making ended abruptly after the first patient suffered a serious adverse event. Now, the therapy…

STAT+: A possible comeback for a failed sickle cell gene therapy

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Thursday 5 November →